James W Rocco Selected Research

James W Rocco Research Topics

Disease

33	Neoplasms (Cancer) 02/2024 - 10/2005
20	Squamous Cell Carcinoma of Head and Neck 08/2023 - 11/2005
6	Head and Neck Neoplasms (Head and Neck Cancer) 11/2023 - 11/2005
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020 - 01/2004
4	Infections 12/2023 - 05/2015
4	Oropharyngeal Neoplasms 12/2023 - 08/2013
4	Wounds and Injuries (Trauma) 11/2023 - 05/2015
3	Carcinoma (Carcinomatosis) 03/2024 - 10/2005
3	Neoplasm Metastasis (Metastasis) 01/2019 - 12/2017
3	Surgical Wound Infection 01/2017 - 05/2015
2	Carcinogenesis 02/2014 - 12/2006
1	Thyroid Neoplasms (Thyroid Cancer) 02/2024
1	Anaplastic Thyroid Carcinoma 02/2024
1	Hemorrhage 12/2023
1	Sepsis (Septicemia) 12/2023
1	Pneumonia (Pneumonitis) 12/2023
1	Hypothyroidism 11/2023
1	Fistula 11/2023
1	Verrucous Carcinoma 10/2022
1	Ischemia 01/2022
1	Osteonecrosis (Kienbock's Disease) 01/2022
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2020
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2019
1	Margins of Excision 07/2017
1	Extranodal Extension 07/2017
1	Airway Obstruction (Choking) 09/2014
1	Myofibroma 09/2014

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 06/2023 - 02/2010
5	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 03/2013
4	Proteins (Proteins, Gene)FDA Link 08/2013 - 12/2006
3	NivolumabIBA 01/2022 - 03/2021
3	Cetuximab (Erbitux)FDA Link 01/2022 - 03/2021
2	ElectrolytesIBA 12/2023 - 11/2023
2	Circulating Tumor DNAIBA 01/2023 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2016
2	Estrogen Receptor alphaIBA 01/2021 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 07/2017 - 03/2009
2	Clindamycin (Cleocin)FDA LinkGeneric 01/2017 - 05/2015
2	MicroRNAs (MicroRNA)IBA 02/2011 - 12/2006
2	Protein Isoforms (Isoforms)IBA 02/2011 - 05/2006
1	Androgen Receptors (Androgen Receptor)IBA 03/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023
1	abemaciclibIBA 08/2023
1	Cyclin DIBA 08/2023
1	Immune Checkpoint InhibitorsIBA 07/2022
1	Diphosphonates (Bisphosphonates)IBA 01/2022
1	TitaniumIBA 01/2022
1	LigandsIBA 01/2022
1	cyclopropapyrroloindoleIBA 03/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Messenger RNA (mRNA)IBA 01/2019
1	Crystalloid SolutionsIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 11/2015
1	Methicillin (Metin)FDA Link 05/2015
1	Concatenated DNAIBA 02/2014
1	Transcription Factors (Transcription Factor)IBA 02/2011
1	PlatinumIBA 03/2009
1	Carrier Proteins (Binding Protein)IBA 08/2008
1	Tumor Protein p73IBA 10/2006
1	Phosphotransferases (Kinase)IBA 11/2005
1	ErbB Receptors (EGF Receptor)IBA 11/2005
1	Gefitinib (Iressa)FDA Link 11/2005
1	Tyrosine Kinase InhibitorsIBA 11/2005
1	Amifostine (Ethyol)FDA LinkGeneric 10/2005
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2005
1	Small Interfering RNA (siRNA)IBA 01/2004

Therapy/Procedure

19	Therapeutics 01/2022 - 12/2006
6	Radiotherapy 10/2022 - 10/2005
4	Free Tissue Flaps 01/2018 - 05/2015
3	Drug Therapy (Chemotherapy) 01/2020 - 02/2010
2	Chemoradiotherapy 01/2021 - 01/2020
2	Adjuvant Radiotherapy 01/2020 - 01/2018
2	Laryngectomy 01/2019 - 01/2019
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2024
1	Patient Readmission 11/2023
1	Conservative Treatment 01/2022
1	Immunotherapy 01/2022
1	Palliative Care (Palliative Therapy) 03/2021
1	Lasers (Laser) 12/2020
1	Adjuvant Chemotherapy 01/2020
1	Perioperative Period 01/2019
1	Neck Dissection (Radical Neck Dissection) 01/2019
1	Gastrostomy 01/2019
1	Surgical Flaps 01/2017
1	Antibiotic Prophylaxis 01/2016
1	Tracheotomy 09/2014
1	Aftercare (After-Treatment) 02/2009